COVID‐19 pneumonia suspected to be co‐infection with Mycoplasma pneumoniae and improved by early administration of favipiravir and ciclesonide

COVID‐19 pneumonia suspected to be co‐infection with Mycoplasma pneumoniae and improved by early administration of favipiravir and ciclesonide

Abstract A female nurse in her 40s caring for a patient with severe coronavirus disease 2019 (COVID‐19) pneumonia treated with a high‐flow nasal cannula (HFNC) presented with fever, cough and dyspnoea. Based on imaging findings and a positive reverse transcription‐polymerase chain reaction (RT‐PCR)...

Full description

Bibliographic Details
Main Authors: Keima Ito, Takako Yokoyama, Minoru Horiuchi, Munehiro Kato, Ikuji Usami
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Respirology Case Reports
Subjects:
ciclesonide
COVID‐19
favipiravir
high‐flow nasal cannula
Mycoplasma pneumoniae
Online Access:https://doi.org/10.1002/rcr2.821

Internet

https://doi.org/10.1002/rcr2.821

Similar Items